Propel: What If Every Complaint Connected Back to Design?

Overview: How Propel’s AI-Driven PLM & QMS Platform Transforms Medical Device Development

Propel is a cloud-native platform that unifies product lifecycle management (PLM) and quality management (QMS), connecting product records, engineering changes and quality workflows for medical device development. It addresses a bottleneck: design information, component data and quality activities managed in separate systems. A shared product record links bills of materials, documents, supplier information and change processes, reducing the need to reconcile different versions before making decisions.

Its embedded AI functionality, Propel One, uses Salesforce’s Agentforce architecture to analyse product data and assist with repetitive tasks. Documented capabilities include summarising engineering changes for non-technical stakeholders, identifying potential issues during change reviews and supporting product-data analysis. Alongside configurable workflows and revision comparisons, these functions can make complex updates easier to assess while keeping the underlying product information available for review.

In medical device workflows, the value is continuity between development and downstream operations. CAD and enterprise-system integrations can reduce manual data transfers, while connected supplier and quality records provide context for evaluating changes. Potential benefits include less administrative effort and faster, better-informed change reviews; however, results depend on data quality, configuration and integration scope rather than AI alone.

Last checked on October 28, 2026: Propel remains active, with recent releases adding production MCP connectivity for AI access to product records and Manufacturing Hub integration with 12 ERP platforms.

What is Propel?

Propel is a Salesforce-based cloud platform that unifies product lifecycle management (PLM) and quality management (QMS), supporting product records, bills of materials, engineering changes and supplier-quality workflows. It serves manufacturers, including MedTech companies, whose engineering, quality and operations teams need shared product data. Its technical approach combines a unified product record with Propel One, embedded AI built on Salesforce Agentforce that supports change summaries, change-impact analysis and product-data analysis within existing permissions and configurations.

Intended Use and Limitations

• Propel reports SOC 2 Type II compliance and makes its report available on request; buyers should verify the current audit period and scope.

• Propel undergoes periodic Salesforce AppExchange Security Reviews, which assess application security and potential vulnerabilities.

• Published security measures include encryption in transit, default encryption at rest on Salesforce Hyperforce, intrusion detection and regular penetration testing.

• Propel supplies validation documentation, including requirements, risk assessments, IQ/OQ materials, PQ templates and traceability matrices; these support rather than replace customer validation.

• Propel documents support for FDA 21 CFR Part 11 electronic-record and electronic-signature requirements; this does not constitute FDA approval or clearance of the platform.

• Its Trust Center describes support for customers’ ISO 9001 and ISO 13485 requirements, while attributing ISO 27001 credentials to the underlying platform rather than establishing Propel’s own certification.

• A named Advanced Sterilization Products case study documents deployment of unified PLM–QMS workflows and electronic MedWatch 3500A submissions; this is vendor-published customer evidence, not an independent evaluation.

• Propel’s AI-enabled MCP connections are documented as operating through existing security and governance controls, making permission management an important implementation consideration.

• Salesforce Ventures led Propel’s $20 million Series C financing in September 2021, demonstrating institutional backing but not establishing its current financial position.